MYO News

Μια σημαντική επιτυχία για την Ελλάδα και το Eλληνικό οικοσύστημα ψηφιακών δεδομένων υγείας αποτελεί η επιλογή Ελληνικής κοινοπραξίας στο νέο Framework Contract των οργανισμών ΕΜΑ (European […]

Η Ελληνίδα ιδρύτρια και CEO της MYO Health Μυρσίνη Ουζουνέλλη αναλαμβάνει τον ρόλο του μέλους της κριτικής επιτροπής για τον επιταχυντή του Ευρωπαϊκού Συμβουλίου Καινοτομίας. Η κ. Ουζουνέλλη χει ήδη υπηρετήσει ως […]

Following a decade of collaboration with the Horizon-EIC on grant financing, the CEO of MYO Health has been invited to collaborate with the EIC’s venture capital […]

We are pleased to announce the incorporation of our new office in the United Kingdom (71-75 Shelton Street, Covent Garden, WC2H 9JQ, UK). Specializing in providing […]

The main theme of the 2021 HTA conference is the new role that HTA and Negotiations are called upon to take on, in the context of […]

CS-45™ was developed by MYO Health to boost HTA submissions. A new tool in the services of HTA in Greece. Call us for a presentation of […]

MIT-EF stages an annual competition by which it selects the most promising early stage technology start-ups in the world, to support them with awards and ongoing […]

Myrsini Ouzounelli, CEO of MYO Health was appointed advisor to Endovention Incorporation, in support of the company’s reimbursement strategy in Europe. Located in San Francisco, California, […]

Interview: MYO Health in Greece

Myrsini Ouzounelli, CEO of MYO Health, was appointed Judge and Mentor to MIT University’s Enterprise Forum 2019 (MIT-EF). MIT-EF stages an annual competition by which it […]

Pharma Health and Business

MYO Health completed and submitted the Value Dossier of Epidiolex® for market access in the United States, to its partner and primary contractor, Strategic Health Resources. […]

MYO supported with a Corporate Participation the 4th MedTech annual conference that took place in Divani Caravel Hotel on the 20th of November, 2018 . An […]

MYO opened an office in Athens, Greece in response to recent changes in the regulatory and reimbursement environment in the country, including the formation of the […]

The CEO of ΜΥΟ was appointed Expert Advisor to the European Commission for the evaluation of Medical Technologies for years 2018 and 2019. In this advisory […]